CRTX

Crism Therapeutics (CRTX)

Crism Therapeutics Corporation

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:LSE:CRTX

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/03	23 : 25	RNS Regulatory News	Crism Therapeutics Corporation Director Dealing	LSE:CRTX	Crism Therapeutics Corporation
2024/06/01	05 : 58	Alliance News	IN BRIEF: Crism has first day of trade on AIM after name change, buy	LSE:CRTX	Crism Therapeutics Corporation
2024/05/31	15 : 00	RNS Regulatory News	Crism Therapeutics Corporation Admission to Trading and First Day of Dealings	LSE:CRTX	Crism Therapeutics Corporation
2009/12/19	03 : 45	PR Newswire (US)	Cornerstone Therapeutics to Host Conference Call to Discuss Financial Guidance for 2010	NASDAQ:CRTX
2009/11/21	05 : 40	PR Newswire (US)	Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal	NASDAQ:CRTX
2009/11/16	22 : 00	PR Newswire (US)	Cornerstone Therapeutics to Present at the 6th Annual Lazard Capital Markets Healthcare Conference	NASDAQ:CRTX
2009/11/13	22 : 00	PR Newswire (US)	Cornerstone Therapeutics Appoints General Counsel	NASDAQ:CRTX
2009/11/04	21 : 00	PR Newswire (US)	Cornerstone Therapeutics Reports Third Quarter 2009 Financial Results	NASDAQ:CRTX
2009/10/21	21 : 00	PR Newswire (US)	Cornerstone Therapeutics to Host Third Quarter 2009 Conference Call	NASDAQ:CRTX
2009/09/03	21 : 01	PR Newswire (US)	Cornerstone Therapeutics Receives Approval to Acquire Commercial Rights to the Antibiotic Factive(R)	NASDAQ:CRTX
2009/09/03	21 : 00	PR Newswire (US)	Cornerstone Therapeutics to Present at Two Upcoming Investor Conferences	NASDAQ:CRTX
2009/07/20	21 : 00	PR Newswire (US)	Cornerstone Therapeutics' David Price Named 2009 Chief Financial Officer of the Year by the Triangle Business Journal	NASDAQ:CRTX
2009/07/16	08 : 04	PR Newswire (US)	Cornerstone Therapeutics Submits Regulatory Filing for Extended-Release Antitussive Product	NASDAQ:CRTX
2009/07/09	05 : 15	PR Newswire (US)	Cornerstone Therapeutics Inc. Announces Record Date and Meeting Date for Special Meeting of Stockholders for Vote with Respect t	NASDAQ:CRTX
2009/06/13	05 : 35	Dow Jones News	UPDATE:FDA Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
2009/06/13	04 : 28	Dow Jones News	FDA: Updates Singulair Label For Neuropsychiatric Events	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
2009/05/20	05 : 01	PR Newswire (US)	Cornerstone Therapeutics Announces Management Change	NASDAQ:CRTX
2009/05/07	20 : 01	PR Newswire (US)	Cornerstone Therapeutics Announces $70 Million Strategic Transaction With Chiesi Farmaceutici SpA	NASDAQ:CRTX
2009/05/07	20 : 00	PR Newswire (US)	Cornerstone Therapeutics Reports First Quarter 2009 Financial Results	NASDAQ:CRTX
2009/04/27	21 : 00	PR Newswire (US)	Cornerstone Therapeutics to Host First Quarter 2009 Conference Call	NASDAQ:CRTX
2009/01/14	07 : 33	Dow Jones News	UPDATE: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
2009/01/14	05 : 34	Dow Jones News	FDA: Singular, Zyflo Asthma Drug Safety Review Continues	NASDAQ:CRTX	Cornerstone Therapeutics Inc.
2008/11/05	22 : 00	PR Newswire (US)	Cornerstone Therapeutics Announces New Board of Directors	NASDAQ:CRTX
2006/08/01	23 : 00	PR Newswire (US)	Critical Therapeutics Files Controlled Release Formulation of Zileuton	NASDAQ:CRTX